scholarly journals Management of the Jehovah's Witness Oncology Patient: Perspective of the Transfusion Service

1995 ◽  
Vol 2 (6) ◽  
pp. 552-556 ◽  
Author(s):  
Kaaron Benson
Keyword(s):  
Patient Perspective ◽  
Morbidity And Mortality ◽  
Blood Component ◽  
Blood Transfusions ◽  
Oncology Patient ◽  
Jehovah’S Witness ◽  
Patients With Cancer ◽  
Jehovah's Witness ◽  
Long Term Prognosis

Due to refusal of blood component transfusions, Jehovah's Witness patients with cancer present a challenge to oncologists who must find appropriate and acceptable treatments. In order to assess the morbidity and mortality that these patients suffer, a retrospective review was conducted of all 58 Jehovah's Witness patients treated at our center from October 1986 through February 1994. This study showed that (1) younger Jehovah's Witness patients or their parents were more likely to accept blood transfusion than older Jehovah's Witness patients, (2) considerable risk of acute morbidity and mortality occurred in patients who refused blood when blood transfusions were indicated, and (3) long-term prognosis may be worsened for some Jehovah's Witness patients due to limited treatment provided in those with anemia or with anticipated anemia.

scholarly journals Successful treatment of total placenta previa by multidisciplinary therapy in a Jehovah’s Witness patient who refused blood transfusions

2018 ◽  
pp. bcr-2018-226486
Author(s):  
Sayaka Tachi ◽  
Noriko Yoneda ◽  
Satoshi Yoneda ◽  
Shigeru Saito
Keyword(s):  
Placenta Previa ◽  
Blood Transfusions ◽  
Multidisciplinary Therapy ◽  
Jehovah’S Witness ◽  
Blood Salvage ◽  
Jehovah's Witness ◽  
Balloon Catheters ◽  
Acute Normovolaemic Haemodilution ◽  
Witness Patient ◽  
Intraoperative Blood Salvage

A 35-year-old Jehovah’s Witness patient with total placenta previa was referred to our hospital at 30 weeks of gestation. She refused autologous and allogeneic blood transfusions, but agreed to receive acute normovolaemic haemodilution, intraoperative blood salvage and biological products. At 35 weeks, she underwent emergent caesarean delivery because of labour pains. Multidisciplinary therapy, including the insertion of balloon catheters into the bilateral common iliac arteries, acute normovolaemic haemodilution and intraoperative blood salvage, avoided hysterectomy; however, blood loss included amniotic fluid which was estimated to be 1910 mL. These treatments may be effective for total placenta previa in blood-refusal patients.

scholarly journals El paciente testigo de Jehová : la negativa al tratamiento médico en situación de gravedad y la circular 1/2012 de la Fiscalía General del Estado

2012 ◽  
Author(s):  
José Ramón Díez Rodríguez
Keyword(s):  
Pregnant Woman ◽  
Medical Treatment ◽  
Patient Autonomy ◽  
Blood Transfusions ◽  
Health Law ◽  
Medical Treatments ◽  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Para Determinar ◽  
Witness Patient

El paciente testigo de Jehová y su rechazo a determinados tratamientos médicos, en concreto a las transfusiones de sangre, constituye uno de los problemas fundamentales con el que históricamente se ha tenido que enfrentar el derecho sanitario. La actual Ley 41/2002 de autonomía del paciente parece dejar claro el supuesto del paciente mayor de edad y la posibilidad de rechazar tratamientos médicos, pero mayores problemas plantean los supuestos del menor de edad, y especialmente la figura del menor maduro, y el supuesto de la mujer embarazada testigo de Jehová. Será necesario atender a la proporcionalidad de derechos en conflicto para determinar los criterios que en cada caso nos permitan inclinar la balanza a favor de una u otra posición.The Jehovah’s Witness patient and their rejection of certain medical treatments, namely blood transfusions, is one of the fundamental problems with which historically had to face the health law. The current Law 41/2002 of patient autonomy seems to clarify the adult patient’s adult and their possibility of refusing medical treatment, but major problems posed minor assumptions, especially the mature minor figure, and the course pregnant woman Jehovah’s Witness. It will be necessary to address the proportionality of conflicting rights, and determining criteria in each case allow us to tip the balance in favor of one position or another.

Comprehensive Geriatric Assessment for Older Patients With Cancer

2007 ◽  
Vol 25 (14) ◽  
pp. 1824-1831 ◽  
Author(s):  
Martine Extermann ◽  
Arti Hurria
Keyword(s):  
Older Adults ◽  
Geriatric Assessment ◽  
Comprehensive Geriatric Assessment ◽  
Cancer Care ◽  
Older Patients ◽  
Morbidity And Mortality ◽  
Psychological State ◽  
Future Research ◽  
Oncology Patient ◽  
Patients With Cancer

Purpose During the last decade, oncologists and geriatricians have begun to work together to integrate the principles of geriatrics into oncology care. The increasing use of a comprehensive geriatric assessment (CGA) is one example of this effort. A CGA includes an evaluation of an older individual's functional status, comorbid medical conditions, cognition, nutritional status, psychological state, and social support; and a review of the patient's medications. This article discusses recent advances on the use of a CGA in older patients with cancer. Methods In this article, we provide an update on the studies that address the domains of a geriatric assessment applied to the oncology patient, review the results of the first studies evaluating the use of a CGA in developing interventions to improve the care of older adults with cancer, and discuss future research directions. Results The evidence from recent studies demonstrates that a CGA can predict morbidity and mortality in older patients with cancer. Accumulating data show the benefits of incorporating a CGA in the evaluation of older patients with cancer. Prospective trials evaluating the utility of a CGA to guide interventions to improve the quality of cancer care in older adults are justified. Conclusion Growing evidence demonstrates that the variables examined in a CGA can predict morbidity and mortality in older patients with cancer, and uncover problems relevant to cancer care that would otherwise go unrecognized.

Bilateral sequential lung transplantation in Jehovah’s Witnesses

Perfusion ◽  
2020 ◽  
pp. 026765912093936
Author(s):  
Ernest G Chan ◽  
Matthew R Morrell ◽  
Patrick G Chan ◽  
Pablo G Sanchez
Keyword(s):  
Lung Transplantation ◽  
Organ Transplantation ◽  
Solid Organ Transplantation ◽  
Limited Resource ◽  
Solid Organ ◽  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Long Term Follow Up

The ethical concerns of refusing lifesaving treatments after receiving an already limited resource such as a solid organ transplantation in a Jehovah’s Witness patient have been discussed in the literature. Many of these studies have concluded that with a multidisciplinary approach, solid organ transplantation is possible in the setting of Jehovah’s Witness patients. To date, there are no reported cases of bilateral sequential lung transplantation in the literature. We report two successful cases of bilateral sequential lung transplantation in Jehovah’s Witness patients with excellent long-term follow-up.

scholarly journals Postpartum atypical haemolytic uremic syndrome: a rare case report

2020 ◽  
Vol 9 (11) ◽  
pp. 4710
Author(s):  
Neha Khatod ◽  
Shubhra Mukharjee ◽  
Vijay Malviya
Keyword(s):  
Renal Failure ◽  
Rare Case ◽  
Blood Transfusions ◽  
Haemolytic Uremic Syndrome ◽  
Aggressive Management ◽  
Rare Case Report ◽  
Uremic Syndrome ◽  
Long Term Prognosis ◽  
In Pregnancy

Hemolytic uremic syndrome (HUS) is characterized by triad of microangiopathic hemolytic anaemia, Thrombocytopenia and Acute renal failure. Genetically predisposed women develop HUS and may be triggered by pregnancy. The diagnosis is challenging due to overlapping clinical features of other diseases in pregnancy. The long-term prognosis is guarded. We are presenting a case of a young primigravida who underwent emergency lower (uterine) segment caesarean section (LSCS). She developed progressive anaemia, thrombocytopenia and renal failure postoperatively. Aggressive management with plasmapheresis, blood transfusions and hemodialysis saved her life. She is currently in remission.

Long-term ECMO treatment in Jehovah’s Witness patient without transfusions

Perfusion ◽  
2012 ◽  
Vol 27 (4) ◽  
pp. 332-334 ◽  
Author(s):  
J Lindholm ◽  
K Palmér ◽  
B Frenckner
Keyword(s):  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Witness Patient ◽  
Ecmo Treatment
Sign in / Sign up

Export Citation Format

Share Document